|
 |
| home > epc > winter 2001 > a competitive analysis of the japanese pharmaceutical and biotechnology industries |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
At the time of writing, Taisho Pharmaceutical Co Ltd and Tanabe Seiyaku Co Ltd have announced a merger under the tentative name of Taisho Tanabe Pharma Group. Both companies were in the top tier of Japanese pharmaceutical companies, with sales of 274 billion yen and 194 billion yen respectively, for the financial year end of March 2001. The question that now arises from the rhetoric of the Japanese pharmaceutical market is: does the merger mark the new beginning of the long awaited consolidation of the Japanese market? Or, is this a one-off event within the industry and what prospects exist for other Japanese pharmaceutical companies?
Japan is always described in any pharmaceutical journal as being the second largest pharmaceutical market in the world. Combine this with the prospect of a population of 127 million people, a drug expenditure of £355 per head, and the fastest ageing population in the world, and you have a market that is ripe for picking.
So why is there such a limited presence of foreign pharmaceutical companies in the marketplace and why are Japanese pharmaceutical companies so worried about their future prospects?
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Discovery Summit 2010
22-24 March 2010, Cannes, France
The Discovery Summit 2010 will highlight the industry’s current challenges and opportunities on a global level through international keynote presentations and case studies delivered by the most esteemed thought leaders in the industry.
More info >> |
|
 |
News and Press Releases |
 |
2010 BIO International Convention Expected to Bring More Than $25 Million to Chicago
The Biotechnology Industry Organization announced today that the 2010 BIO International Convention is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau. The BIO International Convention returns to Chicago on 3rd-6th May and is expected to draw 15,000 to 17,000 industry leaders from 48 states and 60 countries.
More info >> |
|
 |
